Docetaxel and exisulind in previously treated non-small cell lung cancer (NSCLC) patients: a multicenter, phase II clinical trial.

Docetaxel and exisulind in previously treated non-small cell lung cancer (NSCLC) patients: a multicenter, phase II clinical trial. J Thorac Oncol. 2007 Oct; 2(10):933-8.

View in: PubMed

subject areas

Adenocarcinoma
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Large Cell
Carcinoma, Non-Small-Cell Lung
Carcinoma, Squamous Cell
Combined Modality Therapy
Dose-Response Relationship, Drug
Female
Humans
Lung Neoplasms
Male
Maximum Tolerated Dose
Middle Aged
Neoplasm Staging
Prognosis
Radiotherapy Dosage
Remission Induction
Sulindac
Survival Rate
Taxoids
Treatment Outcome

authors with profiles

Everett E. Vokes